Drug Type TCR-T Cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism MAGEA3 modulators(Melanoma-associated antigen 3 modulators), Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | United States | 07 Feb 2014 | |
Kidney Neoplasms | Phase 2 | United States | 07 Feb 2014 | |
Melanoma | Phase 2 | United States | 07 Feb 2014 | |
Uterine Cervical Cancer | Phase 2 | United States | 07 Feb 2014 |